Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease

Ruben Y. Gabriëls; Arno R. Bourgonje; Julius Z. H. von Martels; Guido Trentadue; Tjasso Blokzijl; Hendrik M. Dullemen, van; E. A. M. Festen; Marijn C. Visschedijk; Rinse K. Weersma; Gürsah Kats-Ugurlu; Klaas Nico Faber; G. Dijkstra

Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease

Ruben Y. Gabriëls, Arno R. Bourgonje, Julius Z. H. von Martels, Guido Trentadue, Tjasso Blokzijl, Hendrik M. Dullemen, van, E. A. M. Festen, Marijn C. Visschedijk, Rinse K. Weersma, Gürsah Kats-Ugurlu, Klaas Nico Faber, G. Dijkstra

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	United European Gastroenterology Journal
Publication status	Published - Oct-2019

Handle.net

Persistent link

Embargoed Document

Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in inflammatory Bowel Disease
Final publisher's version, 106 KB
Request copy

Cite this

Gabriëls, R. Y., Bourgonje, A. R., von Martels, J. Z. H., Trentadue, G., Blokzijl, T., Dullemen, van, H. M., Festen, E. A. M., Visschedijk, M. C., Weersma, R. K., Kats-Ugurlu, G., Faber, K. N., & Dijkstra, G. (2019). Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease. United European Gastroenterology Journal.

@article{76c123352e414a31ac1c6c7dd9238ec2,

title = "Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease",

author = "Gabri{\"e}ls, {Ruben Y.} and Bourgonje, {Arno R.} and {von Martels}, {Julius Z. H.} and Guido Trentadue and Tjasso Blokzijl and {Dullemen, van}, {Hendrik M.} and Festen, {E. A. M.} and Visschedijk, {Marijn C.} and Weersma, {Rinse K.} and G{\"u}rsah Kats-Ugurlu and Faber, {Klaas Nico} and G. Dijkstra",

year = "2019",

month = oct,

language = "English",

journal = "United European Gastroenterology Journal",

issn = "2050-6406",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease

AU - Gabriëls, Ruben Y.

AU - Bourgonje, Arno R.

AU - von Martels, Julius Z. H.

AU - Trentadue, Guido

AU - Blokzijl, Tjasso

AU - Dullemen, van, Hendrik M.

AU - Festen, E. A. M.

AU - Visschedijk, Marijn C.

AU - Weersma, Rinse K.

AU - Kats-Ugurlu, Gürsah

AU - Faber, Klaas Nico

AU - Dijkstra, G.

PY - 2019/10

Y1 - 2019/10

M3 - Meeting Abstract

SN - 2050-6406

JO - United European Gastroenterology Journal

JF - United European Gastroenterology Journal

ER -